AlphaYouTM
Insider selling
Tilak Mandadi sold $6.2M of CVS HEALTH Corp (CVS) stock
Tilak Mandadi, EVP, Chief Exp & Tech Officer of CVS HEALTH Corp (CVS), sold 69,551 shares of CVS stock worth $6.2M, per an SEC Form 4 filed May 11, 2026.
It was an open-market sale.
The trade happened on May 8, 2026, 3 days before it was made public.
CVS has moved -3.3% since the trade date, from $90.55 to $87.60 (Sep 21, 2026 close).
- Traded
- May 8, 2026
- Disclosed
- May 11, 2026
- Filing delay
- 3 days
- Price since
- -3.3%
- Role
- EVP, Chief Exp & Tech Officer
- Source
- SEC Form 4
More CVS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.